ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

GEN Genuit Group Plc

435.00
3.00 (0.69%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Genuit Group Plc GEN London Acción Ordinaria
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
3.00 0.69% 435.00 10:35:13
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
434.00 430.50 438.50 435.00 432.00
más cotizaciones de acciones »
Sector Industrial de la empresa
INDUSTRIAL ENGINEERING

Noticias Recientes

Fecha Hora Fuente Noticia
24/4/202404:39UK RNSGenuit Group PLC Notice of AGM
10/4/202410:24UK RNSGenuit Group PLC Director/PDMR Shareholding
10/4/202410:17UK RNSGenuit Group PLC Director/PDMR Shareholding
09/4/202410:28UK RNSGenuit Group PLC Director Declaration
02/4/202409:56UK RNSGenuit Group PLC Director/PDMR Shareholding
20/3/202410:27UK RNSGenuit Group PLC Director/PDMR Shareholding
12/3/202405:40ALNCNewsGenuit revenue drops on lower divisional sales but profit..
12/3/202402:09ALNCNews*Genuit says 2024 trading has started in line w/..
12/3/202402:00UK RNSGenuit Group PLC Final Results
01/3/202402:30UK RNSGenuit Group PLC Director Declaration
19/2/202403:00UK RNSGenuit Group PLC Notice of Results and Investor Presentation
23/1/202409:49UKREGGenuit Group PLC Holding(s) in Company
23/1/202405:24UKREGGenmab A/S Genmab Announces Net Sales Of Darzalex(R)..
22/1/202417:40UKREGGenmab A/S Genmab Announces Decision In Arbitration Appeal..
09/1/202405:45UKREGGenmab A/S Tivdak(R) (tisotumab vedotin-tftv) Supplemental..
02/1/202423:55UKREGGenmab A/S Transactions With Shares And Linked Securities In..
02/1/202408:52UKREGGenmab A/S Genmab To Present At The 42nd Annual J.P. Morgan..
12/12/202306:00UKREGGenmab A/S Genmab To Hold 2023 R&D Update And Ash Data..
09/12/202311:00UKREGGenmab A/S New Pivotal Data For Bispecific Antibody..
05/12/202316:26UKREGGenmab A/S Capital Increase In Genmab As A Result Of..
27/11/202306:00UKREGGenmab A/S Genmab Announces Positive Regulatory Updates For..
22/11/202301:00UKREGGenuit Group PLC Strategy Progress Update Notification
21/11/202315:45UKREGGenmab A/S Transactions With Shares And Linked Securities In..
21/11/202315:42UKREGGenmab A/S Grant Of Restricted Stock Units To Board Members..
15/11/202303:03ALNCNewsGenuit shares rise as annual profit predicted to exceed..
15/11/202301:00UKREGGenuit Group PLC Trading Update
09/11/202308:14UKREGGenmab A/S Major Shareholder Announcement
09/11/202304:08UKREGGenuit Group PLC Director Declaration
09/11/202304:00UKREGGenmab A/S Genmab To Present At Jefferies London Healthcare..
08/11/202310:09UKREGGenmab A/S Major Shareholder Announcement
07/11/202310:01UKREGGenmab A/S Genmab Announces Financial Results For The First..
02/11/202308:05UKREGGenmab A/S Genmab Announces Multiple Abstracts To Be..
02/11/202306:59UKREGGenuit Group PLC Director/PDMR Shareholding
01/11/202311:00UKREGGenuit Group PLC Block listing Interim Review
01/11/202305:58ALNCNewsIN BRIEF: Genuit confirms interim CFO Tim Pullen as..
01/11/202302:00UKREGGenuit Group PLC Directorate Change
25/10/202310:04UKREGGenuit Group PLC Director/PDMR Shareholding
22/10/202309:30UKREGGenmab A/S Tivdak(R) (tisotumab vedotin-tftv) Significantly..
17/10/202310:05UKREGGenuit Group PLC Director/PDMR Shareholding
17/10/202305:22UKREGGenmab A/S Genmab Announces Net Sales Of Darzalex(R)..
11/10/202309:25UKREGGenuit Group PLC Director/PDMR Shareholding
06/10/202309:59UKREGGenuit Group PLC Director/PDMR Shareholding
28/9/202313:38UKREGGenmab A/S Grant Of Restricted Stock Units And Warrants To..
25/9/202306:45UKREGGenmab A/S Genmab Announces European Commission Approval Of..
25/9/202304:55UKREGGenmab A/S Epkinlytm (epcoritamab) Approved By Japan..
12/9/202313:04UKREGGenmab A/S Capital Increase In Genmab As A Result Of..
11/9/202306:56UKREGGenuit Group PLC Director/PDMR Shareholding
04/9/202314:00UKREGGenmab A/S Genmab And Seagen Announce That Tivdak(R)..
01/9/202305:19ALNCNewsIN BRIEF: Genuit hires former Arm, IQE exec Tim Pullen as..
01/9/202304:24DJNGenuit Appoints Tim Pullen as Interim CFO

Su Consulta Reciente

Delayed Upgrade Clock